Step by Stepa HemeOncBuddy patient portal

Tarlatamab

Illustration: Tarlatamab

Say it: tar-LAT-ah-mab · Brand names: Imdelltra

Tarlatamab is an immunotherapy medicine that links your immune cells to small cell lung cancer cells so your body can attack the cancer.

What it is

It is a special antibody with two arms. One arm grabs a protein called DLL3 on small cell lung cancer cells, and the other arm grabs a protein called CD3 on your T cells (a type of immune cell). This brings your immune cells right next to the cancer so they can attack it.

Often used for

How you get it

You get tarlatamab as an infusion into a vein, and each infusion takes about 1 hour. The first 2 doses are given 1 week apart, and you are watched in a hospital or clinic for about a day after each one. After that, most people get it once every 2 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Side effect guides

Sources

Quick answers

What is Tarlatamab?
Tarlatamab is an immunotherapy medicine that links your immune cells to small cell lung cancer cells so your body can attack the cancer. Brand names: Imdelltra.
What is Tarlatamab used for?
small cell lung cancer that has spread and grown after chemotherapy.
How is Tarlatamab given?
You get tarlatamab as an infusion into a vein, and each infusion takes about 1 hour. The first 2 doses are given 1 week apart, and you are watched in a hospital or clinic for about a day after each one. After that, most people get it once every 2 weeks. Your schedule may be different.
What are the common side effects of Tarlatamab?
Fever, often from cytokine release syndrome. Feeling tired. Changes in taste. Lower appetite. Muscle or bone pain. Constipation. Nausea. Low red blood cells (anemia), which can make you feel weak.
When should I call my care team while taking Tarlatamab?
Fever, chills, fast heartbeat, dizziness, or trouble breathing (possible signs of cytokine release syndrome, a strong immune reaction); Confusion, trouble speaking or writing, shaking, very bad sleepiness, seizures, or feeling not like yourself; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Cough, burning when you pee, or other signs of infection; Yellow skin or eyes, or dark urine.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.